Literature DB >> 8897677

Concordant lung xenograft rejection in a hamster-to-rat model.

T Nagayasu1, K Kawahara, T Takahashi, S Yamamoto, H Ayabe.   

Abstract

This study was conducted to investigate the functional and morphological aspects of orthotopic lung xenograft rejection in a concordant hamster-to-rat donor-recipient species combination. By postoperative day (POD) 3, allotransplanted grafts demonstrated good aeration, but infiltrates were seen in all the xenotransplanted lungs. Antihamster lymphocytotoxic antibody titers increased to 5.2 +/- 1.1 by POD 3 (P < 0.05 vs POD 1) and reached 7.0 +/- 0.8 by POD 5 (P < 0.05 vs PODs 1 and 3). The CD4+/CD8+ ratio in peripheral blood lymphocytes increased significantly on POD 3 (P < 0.05 vs untransplanted), but decreased by POD 5 (P < 0.05). Histologically, on POD 3 the xenotransplanted grafts were characterized by perivascular cellular infiltrates and edema. Cytologically, the cells consisted of small round lymphocytes, monocytes, and occasional neutrophils. Immunohistochemical analysis showed heavy IgM and C3 deposits in the vascular endothelium, without any IgG deposits. Allotransplanted grafts showed moderate W 3/25 + (28.3 +/- 17.3%) and MRC OX8 + (38.7 +/- 0.7%) cellular infiltrations on POD 3, but ED1 + (8.0 +/- 3.7%) cells were rare. Conversely, in the xenotransplanted grafts, ED1 + (34.2 +/- 16.4%) cells were more prevalent than MRC OX8 + (18.1 +/- 16.5%) cells on POD 3, at P < 0.01 and P < 0.05 vs allograft, respectively. These results indicate that both antidonor antibodies and macrophages/monocytes play an important role in the concordant lung xenograft rejection.

Entities:  

Mesh:

Year:  1996        PMID: 8897677     DOI: 10.1007/bf00311638

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Discordant lung xenograft rejection in the rat.

Authors:  R Tavakoli; J Y Devaux; L Nonnenmacher; A Louvel; B Weill; D Houssin
Journal:  Transplantation       Date:  1992-01       Impact factor: 4.939

2.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

3.  Lung allograft rejection in the rat. II. Specific immunological properties of lung grafts.

Authors:  J Prop; C R Wildevuur; P Nieuwenhuis
Journal:  Transplantation       Date:  1985-08       Impact factor: 4.939

4.  Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs.

Authors:  N Murase; T E Starzl; A J Demetris; L Valdivia; M Tanabe; D Cramer; L Makowka
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

5.  Evidence that deoxyspergualin prevents sensitization and first-set cardiac xenograft rejection in rats by suppression of antibody formation.

Authors:  L A Valdivia; M Monden; M Gotoh; Y Nakano; T Tono; T Mori
Journal:  Transplantation       Date:  1990-07       Impact factor: 4.939

6.  Induction of long-term survival of hamster heart xenografts in rats.

Authors:  J van den Bogaerde; R Aspinall; M W Wang; N Cary; S Lim; L Wright; D White
Journal:  Transplantation       Date:  1991-07       Impact factor: 4.939

7.  Baboon-to-human cardiac xenotransplantation in a neonate.

Authors:  L L Bailey; S L Nehlsen-Cannarella; W Concepcion; W B Jolley
Journal:  JAMA       Date:  1985-12-20       Impact factor: 56.272

8.  Beyond hyperacute rejection. Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets.

Authors:  J P Fryer; J R Leventhal; A P Dalmasso; S Chen; P A Simone; J J Goswitz; N L Reinsmoen; A J Matas
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

9.  A crucial effect of splenectomy on prolonging cardiac xenograft survival in combination with cyclosporine.

Authors:  M Monden; L A Valdivia; M Gotoh; N Kubota; Y Hasuike; Y Nakano; J Okamura; T Mori
Journal:  Surgery       Date:  1989-04       Impact factor: 3.982

10.  G(RADA1): a new cell surface antigen of mouse leukemia defined by naturally occurring antibody and its relationship to murine leukemia virus.

Authors:  Y Obata; E Stockert; P V O'Donnell; S Okubo; H W Snyder; L J Old
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.